Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 38

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 3
Chunk 38
---
 extraordinary transaction) not be present
at such a meeting or vote on that matter unless a majority of the directors or members of the audit committee, as applicable, have a personal
interest in the matter. If a majority of the members of the audit committee or the board of directors has a personal interest in the approval
of such a transaction then all of the directors may participate in deliberations of the audit committee or board of directors, as applicable,
with respect to such transaction and vote on the approval thereof and, in such case, shareholder approval is also required.

Pursuant to the Companies Law, extraordinary transactions with
our office holders who are not directors require audit committee approval and subsequent approval by our board of directors. Compensation,
insurance, indemnification or exculpation arrangements for office holders who are not directors require approval by our compensation committee,
followed by our board of directors and, if deviating from our compensation policy, our shareholders as well, via a special majority. Compensation
arrangements with directors, including in their capacities as executive officers, or with our Chief Executive Officer, as well as insurance
(unless exempted under the applicable regulations), indemnification or exculpation of directors or our Chief Executive Officer, require
the approval of the compensation committee, the board of directors and our shareholders, in that order. In the case of our Chief Executive
Officer, the shareholder approval must fulfill, in addition to an ordinary majority, one of the following two special majority requirements:

  at least a majority of the voting rights in the company held by non-controlling shareholders who have no conflict of interest (referred        

  the voting rights held by non-controlling, non-conflicted shareholders (as described in the previous bullet point) who are present        

As described above (concerning votes related to external directors),
a shareholder is presumed to be a controlling shareholder if the shareholder holds 50% or more of the voting rights in the company or
has the right to appoint the majority of the directors of the company or its general manager (chief executive officer). In addition, as
it relates to the approval of related party transactions, a controlling shareholder is furthermore deemed to include any shareholder possessing
25% or more of the voting rights if no other shareholder possesses more than 50% of the voting rights.

If the transaction or compensation arrangement of the office holder
brought for approval amends an existing arrangement, then only the approval of the audit committee or compensation committee (as appropriate)
is required if that committee